We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Assetz Capital is a leading property-secured business marketplace lender in the UK and Europe. It provides loans to small and medium enterprises (SMEs), and property developers in the UK, financed by retail investors, institutional investors, government bodies and banks. The company has arranged loans of over £1 billion since its founding in April 2013. It ranked 53rd out of the UK’s top 100 fastest-growing technology companies for two consecutive years in the Sunday Times Tech Track 100, and funded the equivalent of 1 in 100 UK homes in the last two years. Assetz Capital aims to utilise the investment to fund legal and structuring work around the Coronavirus Business Interruption Loan Schemes (CBILS), have working capital for business development, grow its team, and possibly launch an Initial Public Offering (IPO) in the future.
days to go: Expired investment: £760,600
One of the UK's first peer-to-peer fully FCA-authorised lending platforms that offers investors opportunities to contribute funds towards bridging loans and residential buy-to-let mortgages. LandlordInvest users can invest from £100 in property loans alongside other lenders. The company also offered the first property-backed IFISA in the UK. Since launching in December 2016, investors have lent £5.3m to property owners and have collectively received over £323,000 in interest payments, with zero capital losses. The average LTV ratio on the platform is 63.76% across an average loan value of £204,221. This has resulted in investors earning an average return of 11.37% per annum. LandlordInvest also offer a secondary market, where more than £1.5m has been traded to date. The company has a positive cash flow and has generated a net profit of £4,000. LandlordInvest are now seeking funds to scale the business further by focusing on loan origination and management. Investments will allow the business to hire technical resources, Relationship Managers and Business Development Managers.
days to go: Expired investment: £121,450
Easily understand and manage all your insurance in one simple app, ready for the digital age. Wrisk is all about transparency and allows customers to see how much they’re currently paying for their insurance, what actions they can take to reduce their risk and purchase the insurance seamlessly from within the app. Wrisk is seeking investment to expand and cater for as many insurance needs as possible. 
days to go: Expired investment: £1,044,630
TransferGuru is a money transfer comparison site that aims to get the best deal possible for people transfering money abroad. The user simply inputs the amount they want to send and where they want it to go and they will then be shown all the options, displaying the best price, the best ratings and the fastest way to make the transfer.
days to go: Expired investment: £82,593
Nextfin is an FCA approved aggregation and rating portal for equity and debt crowdfunding investments. AIM is shrinking, legacy stock markets are too expensive to maintain and do not serve the requirements of SMEs, banks are closing branches, lending less and are paying little or no interest to investors. As a result of this, there is a huge growth in equity crowdfunding and P2P lending which has seen the launch of hundreds of alternative lenders & platforms that has created a new c.£3bn marketplace, expanding at 66% p.a. There is no single portal or trusted ratings index for investors to compare on a like for like basis and no secondary market to facilitate exits. * NextFin is the new trading name of Business Agent Ltd The solution NextFin aggregates equity and debt crowdfunding investments to create the alternative finance marketplace. This makes it easy for investors and lenders to find and compare opportunities by presenting all investment offerings in one place. With the addition of a free of charge ratings service investors will be able to view ratings of every equity crowdfunding pitch, every P2P site, and every equity crowdfunding site. NextFin’s technology will constantly track these companies and investments providing the investor real-time intelligence on which to base investment decisions. The platforms and entrepreneurs will be self-promoting and marketing their ratings driving thousands of visitors a month to the NextFin site, in the same way, businesses refer their potential clients to Trip Advisor and Trustpilot. There is an estimated 10 million website/platform visitors per month across the whole of the alternative finance market. NextFin is targeting to direct 5% of this highly profiled traffic to its platform from which it will earn between £5-£8 per click from advertisers and partners. In addition, an in-house brokerage service also earns between 1%-6% commissions on loan placements. A future revenue stream (not featured in the financials) will be developed once visitor traffic reaches critical mass. This will see Nextfin being able to realise the full value of its captured ratings data and visitor traffic by launching a secondary market, which is estimated to be a £5bn marketplace. NextFin is raising £500k at a pre-money valuation of £2M to: • Develop P2P and Equity site ratings• Expand the management, infrastructure and marketing resource• Increase visitor traffic to 6m a year via rating referrals Owing to the size of the market and rapid growth of the industry, enterprise valuations in alternative finance are based on visitor traffic, market share and registered users. Recently published valuations of companies with visitor traffic of over 6m per year are in excess of £70m. NextFin is the market-leading aggregator and has first-mover advantage. It has the potential to exceed these valuations because it is the whole of the market aggregator and is currently the only ratings service provider as it grows to achieve 500,000 visitors p.m.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,057
The Pension Lab offers an interative platform for employees and individuals, helping them reconnect and engage with their pensions. Its mission is to provide the customers with better knowledge of pensions and promote long-term financial decision making. The company has reached the finals of 'Pitchfest' competition held at the NEC as a component of “Venturefest”, and it is also a finalist in the “Innovation in Business” category. Some of the best Fintech solutions providers and pension services such as Yodlee and Origo are in partnership with the Pension Lab. With the proceeds, the company will develop its working capital, infrastructure development, and customer acquisition.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £38,024
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph